sample of business plan proposal college thesis writing services marine biology phd thesis traditional literature review phd dissertation search writing help
Skip to main content

Controlled release of therapeutical agents from polymer brush coatings by employing reversible polymer condensation using ionic cross-linkers


Kurzfassung

  • Surface coat with drug encapsulation for medical implants
  • Triggered drug release by contact with physiological salt concentrations
  • Quickly achieve therapeutic levels at actual site of inflammation

Hintergrund

Soft tissue implants, such as heart valves, catheters and stents are frequently used in cardiovascular diseases. Medical devices that remain in or on the body for short periods of time, such as catheters, artificial bowel outlets and tubes for supplying medication are also widely used. Post-surgery inflammations after implantation are one of the most common problems in modern clinical practice. In a conventional approach, local antibiotic depots, e.g., antibiotic loaded bone cement, are used to reduce inflammatory reactions after implantation. However, these approaches are prone to induce local overdosing and also fail to provide ongoing inflammatory protection during the critical time window. Thus, a repeated administration of antibiotics becomes necessary, which in return often leads to antibiotic resistance of the pathogens.


Bilder & Videos


Lösung

The invention describes a mechanism by which polyanionic or polycationic macromolecules can be condensed into nanoparticles using glycerol and reversibly stabilized with various ionic crosslinkers. This mechanism is used for surface-bound mucin nanoparticles that can store and subsequently release therapeutic agents, such as antibiotics. One possible application is the coating of implants with the inventive mucin-drug complex. Physiological salt concentration trigger the unfolding of the mucins and thus the local release of the encapsulated drug.


Anwendungsbereiche

Coating of medical devices or implants to reduce post-surgery inflammation


Bayerische Patentallianz GmbH


089 5480177-0
kontakt@baypat.de
www.baypat.de
Adresse
Destouchesstr. 68
80796 München



Entwicklungsstand

Machbarkeit


Angebot Anbieter-Website


Kontakt | Geschäftsstelle

TransferAllianz e. V.
Christiane Bach-Kaienburg
(Geschäftsführerin)

c/o TransMIT GmbH
Kerkrader Straße 3
D-35394 Gießen